ESK-001
ESK-001 is a pharmaceutical drug with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 80.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
2
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
80.0%
4 of 5 finished
20.0%
1 ended early
1
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
An Investigational Study to Evaluate the Cardiac Safety Assessment (TQTc Study) of ESK-001
An Investigational Study of ESK-001 in Participants With Normal Renal Function and Participants With Mild, Moderate, and Severe Impaired Renal Function
A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Plaque Psoriasis
An Investigational Study of ESK-001 in Participants With Normal Liver Function and Participants With Mild, Moderate, and Severe Liver Damage
POC Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Active Intermediate, Posterior, or Pan NIU
Clinical Trials (6)
An Investigational Study to Evaluate the Cardiac Safety Assessment (TQTc Study) of ESK-001
An Investigational Study of ESK-001 in Participants With Normal Renal Function and Participants With Mild, Moderate, and Severe Impaired Renal Function
A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Plaque Psoriasis
An Investigational Study of ESK-001 in Participants With Normal Liver Function and Participants With Mild, Moderate, and Severe Liver Damage
POC Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Active Intermediate, Posterior, or Pan NIU
Relative Bioavailability of ESK-001 Tablet Versus Liquid in Healthy Participants
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6